Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus

Proteinuria and albuminuria are established risk factors for progressive renal damage. Albuminuria can be effectively controlled by antihypertensive drugs that interrupt the renin-angiotensin-aldosterone system. However, the efficiency of N-acetyl cysteine (NAC) in preventing diabetic nephropathy is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Iranian journal of kidney diseases 2012-01, Vol.6 (1), p.39
Hauptverfasser:	Rasi Hashemi, Sadreddin, Noshad, Hamid, Tabrizi, Ali, Mobasseri, Majid, Tayebi Khosroshahi, Hamid, Heydarnejad, Masoumeie, Khalaj, Mohammad Reza, Aghamohammadzadeh, Naser
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylcysteine - therapeutic use Adult Aged Angiotensin II Type 1 Receptor Blockers - therapeutic use Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - urine Diabetic Nephropathies - drug therapy Diabetic Nephropathies - urine Drug Therapy, Combination Female Free Radical Scavengers - therapeutic use Humans Losartan - therapeutic use Male Middle Aged Proteinuria - drug therapy Proteinuria - etiology Statistics, Nonparametric
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!